Journal Mobile Options
Table of Contents
Vol. 23, No. 5-6, 2007
Issue release date: May 2007
Section title: Original Paper
Cerebrovasc Dis 2007;23:424–429
(DOI:10.1159/000101466)

Is Transcranial Doppler for the Detection of Venous-to-Arterial Circulation Shunts Reproducible?

Sastry S. · Daly K. · Chengodu T. · McCollum C.
Department of Academic Surgery, South Manchester University Hospital, Manchester, UK

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 10/18/2006
Accepted: 12/4/2006
Published online: 4/2/2007

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: http://www.karger.com/CED

Abstract

Background: We investigated the reproducibility of contrast transcranial Doppler (TCD), a safe non-invasive test for investigation of venous-to-arterial circulation shunts (v-aCS), usually patent foramen ovale, in young stroke patients. We also investigated whether microbubble contrast was reproducible and whether the addition of blood to agitated saline contrast affected the number of microbubbles produced. Methods: TCD investigation for v-aCS was repeated in 42 patients using a standardised protocol (i) by the same investigator and (ii) by a different investigator. Agitated saline was produced by mixing saline and 1 ml of air between two 10-ml syringes. The effect of adding blood and increasing the number of agitations was evaluated by microscopy examination using a haemocytometer to assess bubble numbers and sizes. Results: TCD: no difference was found in the highest microbubble count for the same investigator and between different investigators (p > 0.05). Reproducibility for the detection of v-aCS consistent with a patent foramen ovale was also good (ĸ values >0.8). Contrast: both the number of contrast mixes before injection and the presence of blood significantly increased the number of bubbles counted. On average, 18 agitations produced 1.86 (95% CI 1.62–2.13) times more bubbles than 6 agitations. Mixtures with blood produced on average 3.8 times more bubbles (3.08–4.69). The size of the bubbles was similar for all mixtures. Conclusions: Contrast TCD is reproducible and reliable for the detection of v-aCS. The addition of blood and 18 mixes rather than 6 significantly increased the number of microbubbles produced and may increase the effectiveness of microbubble contrast.


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 10/18/2006
Accepted: 12/4/2006
Published online: 4/2/2007

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: http://www.karger.com/CED


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guerin F, Bousser MG, de Recondo J: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: a study using transesophageal echocardiography. Stroke 1993;24:1865–1873.
  2. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148–1152.
  3. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17–20.
  4. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172–1179.
  5. Knauth M, Ries S, Pohimann S, Kerby T, Forsting M, Daffertshofer M, Hennerici M, Sartor K: Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ 1997;314:701–705.
  6. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648–1651.
  7. Jauss M, Zanette E: Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000;10:490–496.
  8. Baguet JP, Besson G, Tremel F, Mangin L, Richardot C, Mallion JM: Should one use echocardiography or contrast transcranial Doppler ultrasound for the detection of a patent foramen ovale after an ischemic cerebrovascular accident? Cerebrovasc Dis 2001;12:318–324.
  9. Droste DW, Kriete JU, Stypmann J, Castrucci M, Wichter T, Tietje R, Weltermann B, Young P, Ringelstein EB: Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of different procedures and different contrast agents. Stroke 1999;30:1827–1832.
  10. Stoddard MF, Keedy DL, Dawkins PR: The cough test is superior to the Valsalva maneuver in the delineation of right-to-left shunting through a patent foramen ovale during contrast transesophageal echocardiography. Am Heart J 1993;125:185–189.
  11. Sastry S, McNabb S, Daly K, Ray SG, McCollum C: Transcranial Doppler or transoesophageal echocardiography for the detection of venous-to-arterial circulation shunts? Heart 2002;88:29.
  12. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
  13. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135–160.
  14. Markus H, Bland JM, Rose G, Sitzer M, Siebler M: How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke 1996;27:1249–1252.
  15. Maeda H, Etani H, Handa N, Tagaya M, Oku N, Kim BH, Naka M, Kinoshita N, Nukada T, Fukunaga R: A validation study on the reproducibility of transcranial Doppler velocimetry. Ultrasound Med Biol 1990;16:9–14.
  16. Totaro R, Marini C, Cannarsa C, Prencipe M: Reproducibility of transcranial Doppler sonography: a validation study. Ultrasound Med Biol 1992;18:173–177.
  17. Droste DW, Reisener M, Kemeny V, Dittrich R, Schulte-Altedorneburg G, Stypmann J, Wichter T, Ringelstein EB: Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: reproducibility, comparison of 2 agents, and distribution of microemboli. Stroke 1999;30:1014–1018.
  18. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S: Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020–1024.
  19. Teague SM, Sharma MK: Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke 1991;22:740–745.